SynthesisThoracic cancer2022

Efficacy and safety of anti-PD-1/PD-L1 in combination with chemotherapy or not as first-line treatment for advanced non-small cell lung cancer: A systematic review and network meta-analysis.

Liming Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.